Q
QTTB
Q32 BIO INC
2.96
-0.22-6.92%After Hours: 2.980 +0.020 +0.68%19:34 12/12 EST
OPEN/PREV CLOSE3.160/3.180
TODAY RANGE2.850-3.270
VOL329.14K
MARKET CAP36.42M
52 WEEK RANGE1.345-27.61
AVG VOL (3M)3.03M
% TURNOVER2.68%
TURNOVER--
P/E (TTM)-0.8582
% RANGE13.21%
EPS(TTM)-3.4489
P/E(FORWARD)-0.2383
P/B-1.9743
BVPS-1.4993
DIVIDEND--
P/S8.25
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP27.39M
SHARES OUTSTANDING12.30M
NEXT EARNINGS03/09-03/13
FREE FLOAT9.25M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·12/05 00:00
Q32 Bio Inc. CFO and President Lee Kalowski Reports Sale of Common Shares
Reuters·12/05 00:00
Q32 Bio CEO Jodie Pope Morrison Reports Sale of Common Shares
NASDAQ·12/02 08:36
Q32 Bio Sells Complement Inhibitor ADX-097 To Akebia Therapeutics
TipRanks·12/01 18:00
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Benzinga·12/01 17:31
Crude Oil Gains Over 1%; ISM Manufacturing PMI Falls In November
Benzinga·12/01 17:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·12/01 14:58
Dow Dips 200 Points; Q32 Bio Shares Jump
Benzinga·12/01 14:43
Why Is Small-Cap Q32 Bio Stock Soaring On Monday?
TipRanks·12/01 13:24
Why Is Q32 Bio Stock (QTTB) Up Today?
Dow Jones·12/01 12:46
Q32 Bio Sells Lead Product Candidate to Akebia Therapeutics
Benzinga·12/01 12:37
Market-Moving News for December 1st
TipRanks·12/01 12:30
Q32 Bio Sells ADX-097 to Akebia Therapeutics
Reuters·12/01 12:14
Q32 Bio Sells ADX-097 to Akebia for Up to $592 Million
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email : service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.